{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000168","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.927290+00:00","generated_at":"2026-05-16T18:28:01.799407+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"confidence":"high","headline":"Salarius Pharma appoints CEO, CSO, CBO with $225k salary and 35% bonus","bullets":["Frederick E. Pierce appointed CEO, Dr. Barbara Hibner as CSO, Peter Marschel as CBO effective upon merger closing.","Each executive receives annual base salary of $225,000 and target annual bonus of 35% of base salary.","Severance includes $225,000 lump sum plus 9 months COBRA reimbursement if terminated without cause or for good reason.","Employment agreements incorporate at-will status, restrictive covenants, and eligibility for standard benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000168","json":"https://secwatch.observer/filing/0001615219-25-000168.json","markdown":"https://secwatch.observer/filing/0001615219-25-000168.md","text":"https://secwatch.observer/filing/0001615219-25-000168.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000168/0001615219-25-000168-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000168/flks-20251118.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:28:01.799407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}